Literature DB >> 30357460

[Pathological-anatomical diagnosis according to the German lung cancer guideline 2018].

K Junker1, R Büttner2, T Langer3, D Ukena4.   

Abstract

The German S3-guideline on prevention, diagnosis, therapy and follow-up of lung cancer, published in February 2018, expands on the 2010 guideline to include a total of 19 recommendations and statements regarding the "processing of lung resection specimens (tumor resection specimens)", "processing of lymph nodes", "histo-pathological typing and immunophenotype", "extent of tumor growth in resection specimens", "resection margins" or "R-classification", "grade of malignancy (grading)", "regression grading" as well as the "examination of molecular targets". The statements regarding the analysis of molecular targets result from the diagnostic requirements of the current targeted therapy of advanced lung cancer. At the same time, a pathological-anatomical diagnosis according to the current S3-guideline fulfills all corresponding requirements in certified lung cancer centers.

Entities:  

Keywords:  Molecular diagnostics; Non-small-cell lung cancer; Resection margins; TNM-classification; WHO-classification

Mesh:

Year:  2018        PMID: 30357460     DOI: 10.1007/s00292-018-0531-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  20 in total

1.  Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery.

Authors:  Jacquelyn G Hancock; Joshua E Rosen; Alberto Antonicelli; Amy Moreno; Anthony W Kim; Frank C Detterbeck; Daniel J Boffa
Journal:  Ann Thorac Surg       Date:  2014-12-17       Impact factor: 4.330

2.  [Incomplete resections in bronchial carcinoma: morbidity and prognosis].

Authors:  H Dienemann; C Trainer; H Hoffmann; H Bülzebruck; T Muley; K Kayser; I Vogt-Moykopf
Journal:  Chirurg       Date:  1997-10       Impact factor: 0.955

3.  The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.

Authors:  Peter Goldstraw; John Crowley; Kari Chansky; Dorothy J Giroux; Patti A Groome; Ramon Rami-Porta; Pieter E Postmus; Valerie Rusch; Leslie Sobin
Journal:  J Thorac Oncol       Date:  2007-08       Impact factor: 15.609

4.  Significance of lymphangiosis carcinomatosa at the bronchial resection margin in patients with non-small cell lung cancer.

Authors:  B Passlick; I Sitar; W Sienel; O Thetter; A Morresi-Hauf
Journal:  Ann Thorac Surg       Date:  2001-10       Impact factor: 4.330

Review 5.  ALK evaluation in the world of multiplex testing: Network Genomic Medicine (NGM): the Cologne model for implementing personalised oncology.

Authors:  C Heydt; A Kostenko; S Merkelbach-Bruse; J Wolf; R Büttner
Journal:  Ann Oncol       Date:  2016-09       Impact factor: 32.976

Review 6.  Reporting lung cancer pathology specimens. Impact of the anticipated 7th Edition TNM classification based on recommendations of the IASLC Staging Committee.

Authors:  William D Travis
Journal:  Histopathology       Date:  2009-01       Impact factor: 5.087

7.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

8.  Harmonized PD-L1 immunohistochemistry for pulmonary squamous-cell and adenocarcinomas.

Authors:  Andreas H Scheel; Manfred Dietel; Lukas C Heukamp; Korinna Jöhrens; Thomas Kirchner; Simone Reu; Josef Rüschoff; Hans-Ulrich Schildhaus; Peter Schirmacher; Markus Tiemann; Arne Warth; Wilko Weichert; Rieke N Fischer; Jürgen Wolf; Reinhard Buettner
Journal:  Mod Pathol       Date:  2016-07-08       Impact factor: 7.842

9.  Benchmarking of mutation diagnostics in clinical lung cancer specimens.

Authors:  Silvia Querings; Janine Altmüller; Sascha Ansén; Thomas Zander; Danila Seidel; Franziska Gabler; Martin Peifer; Eva Markert; Kathryn Stemshorn; Bernd Timmermann; Beate Saal; Stefan Klose; Karen Ernestus; Matthias Scheffler; Walburga Engel-Riedel; Erich Stoelben; Elisabeth Brambilla; Jürgen Wolf; Peter Nürnberg; Roman K Thomas
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

10.  Increased detection rates of EGFR and KRAS mutations in NSCLC specimens with low tumour cell content by 454 deep sequencing.

Authors:  Evgeny A Moskalev; Robert Stöhr; Ralf Rieker; Simone Hebele; Florian Fuchs; Horia Sirbu; Sergey E Mastitsky; Carsten Boltze; Helmut König; Abbas Agaimy; Arndt Hartmann; Florian Haller
Journal:  Virchows Arch       Date:  2013-03-07       Impact factor: 4.064

View more
  1 in total

1.  RNA-Based Detection of Gene Fusions in Formalin-Fixed and Paraffin-Embedded Solid Cancer Samples.

Authors:  Martina Kirchner; Olaf Neumann; Anna-Lena Volckmar; Fabian Stögbauer; Michael Allgäuer; Daniel Kazdal; Jan Budczies; Eugen Rempel; Regine Brandt; Suranand Babu Talla; Moritz von Winterfeld; Jonas Leichsenring; Tilmann Bochtler; Alwin Krämer; Christoph Springfeld; Peter Schirmacher; Roland Penzel; Volker Endris; Albrecht Stenzinger
Journal:  Cancers (Basel)       Date:  2019-09-05       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.